An efficient deprotection method for 5′-[O,O-bis(pivaloyloxymethyl)]-(E)-vinylphosphonate containing oligonucleotides

[1]  K. G. Rajeev,et al.  Facile Synthesis, Geometry, and 2'-Substituent-Dependent in Vivo Activity of 5'-(E)- and 5'-(Z)-Vinylphosphonate-Modified siRNA Conjugates. , 2018, Journal of medicinal chemistry.

[2]  S. Milstein,et al.  Advanced siRNA Designs Further Improve In Vivo Performance of GalNAc-siRNA Conjugates , 2018, Molecular therapy : the journal of the American Society of Gene Therapy.

[3]  D. Corey,et al.  Chemistry, mechanism and clinical status of antisense oligonucleotides and duplex RNAs , 2017, Nucleic acids research.

[4]  K. Ranganna,et al.  Therapeutic potential of chemically modified siRNA: Recent trends , 2017, Chemical biology & drug design.

[5]  K. G. Rajeev,et al.  Impact of enhanced metabolic stability on pharmacokinetics and pharmacodynamics of GalNAc–siRNA conjugates , 2017, Nucleic acids research.

[6]  W. Litchy,et al.  Trial design and rationale for APOLLO, a Phase 3, placebo-controlled study of patisiran in patients with hereditary ATTR amyloidosis with polyneuropathy , 2017, BMC Neurology.

[7]  A. Akinc,et al.  Targeting of Antithrombin in Hemophilia A or B with RNAi Therapy , 2017, The New England journal of medicine.

[8]  A. Khvorova,et al.  5΄-Vinylphosphonate improves tissue accumulation and efficacy of conjugated siRNAs in vivo , 2017, Nucleic acids research.

[9]  C. Stein,et al.  FDA-Approved Oligonucleotide Therapies in 2017. , 2017, Molecular therapy : the journal of the American Society of Gene Therapy.

[10]  R. Titze-de-Almeida,et al.  The Race of 10 Synthetic RNAi-Based Drugs to the Pharmaceutical Market , 2017, Pharmaceutical Research.

[11]  B. Bettencourt,et al.  A Highly Durable RNAi Therapeutic Inhibitor of PCSK9 , 2017, The New England journal of medicine.

[12]  B. Bettencourt,et al.  Clinical Proof of Concept for a Novel Hepatocyte-Targeting GalNAc-siRNA Conjugate. , 2017, Molecular therapy : the journal of the American Society of Gene Therapy.

[13]  M. Manoharan,et al.  siRNA carrying an (E)-vinylphosphonate moiety at the 5΄ end of the guide strand augments gene silencing by enhanced binding to human Argonaute-2 , 2016, Nucleic acids research.

[14]  I. MacRae,et al.  Structural Analysis of Human Argonaute-2 Bound to a Modified siRNA Guide. , 2016, Journal of the American Chemical Society.

[15]  M. Graham,et al.  Synergistic effect of phosphorothioate, 5'-vinylphosphonate and GalNAc modifications for enhancing activity of synthetic siRNA. , 2016, Bioorganic & medicinal chemistry letters.

[16]  K. G. Rajeev,et al.  5′‐(E)‐Vinylphosphonate: A Stable Phosphate Mimic Can Improve the RNAi Activity of siRNA–GalNAc Conjugates , 2016, Chembiochem : a European journal of chemical biology.

[17]  K. G. Rajeev,et al.  5'-C-Malonyl RNA: Small Interfering RNAs Modified with 5'-Monophosphate Bioisostere Demonstrate Gene Silencing Activity. , 2016, ACS chemical biology.

[18]  Wenyu Li,et al.  Identification of metabolically stable 5′-phosphate analogs that support single-stranded siRNA activity , 2015, Nucleic acids research.

[19]  Amy Chan,et al.  Multivalent N-acetylgalactosamine-conjugated siRNA localizes in hepatocytes and elicits robust RNAi-mediated gene silencing. , 2014, Journal of the American Chemical Society.

[20]  V. Venditto,et al.  Photohydrate‐Mediated Reactions of Uridine, 2′‐Deoxyuridine and 2′‐Deoxycytidine with Amines at Near Neutral pH , 2013, Photochemistry and photobiology.

[21]  Stanley T. Crooke,et al.  Single-Stranded siRNAs Activate RNAi in Animals , 2012, Cell.

[22]  James A. Powell,et al.  Streamlined process for the chemical synthesis of RNA using 2'-O-thionocarbamate-protected nucleoside phosphoramidites in the solid phase. , 2011, Journal of the American Chemical Society.

[23]  P. Hadwiger,et al.  Characterization of side reactions during the annealing of small interfering RNAs. , 2011, Analytical biochemistry.

[24]  K. G. Rajeev,et al.  Utilizing Chemistry to Harness RNA Interference Pathways for Therapeutics: Chemically Modified siRNAs and Antagomirs , 2007 .

[25]  Javier Martinez,et al.  The human RNA kinase hClp1 is active on 3′ transfer RNA exons and short interfering RNAs , 2007, Nature.

[26]  T. Wada,et al.  Nitromethane as a scavenger of acrylonitrile in the deprotection of synthetic oligonucleotides , 2005 .

[27]  Jim Arnold,et al.  Synthesis of High-Quality Antisense Drugs. Addition of Acrylonitrile to Phosphorothioate Oligonucleotides: Adduct Characterization and Avoidance , 2003 .

[28]  Leemor Joshua-Tor,et al.  Slicer and the argonautes. , 2007, Nature chemical biology.